-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients with r/r MM: 83% CR rate, 91% MRD negativity, and 50% of patients in ≥CR at 15 months -- -- Case ...
Calls for revenge as senior Iranian officials appear in public for supreme leader's funeral Super typhoon with 180-mph winds about to slam US islands devastated just 3 months ago 'No one is above the ...
In this episode, Curtiss T. Stinis, MD, FACC, FSCAI, Clinical Professor of Medicine, Director of Peripheral Interventions, Interventional Cardiology, Scripps Clinic, joins the Becker’s Healthcare ...
15 out of 18 complete responders, or 83%, demonstrated ongoing complete responses for at least 36 months without any additional treatment for RRP 5 complete responders have ongoing responses beyond 4 ...
The first Minecraft 26.2 pre-release is here for Java Edition, but there's some bad news if you've been taking advantage of the sandbox game's new peer-to-peer multiplayer, which was implemented in a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Good afternoon, everyone. My name is Jim, and I will be your conference operator today. At this time, I would like to welcome everyone to the Protara Therapeutics Lymphatic Malformations KOL Webinar. ...
EyePoint is rated a clear BUY, with central-case DCF modeling indicating roughly 2x upside from current levels. DURAVYU, EYPT's lead candidate for wet AMD and DME, has demonstrated a compelling ...